v3.26.3
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Operating activities    
Net income $ 364,361 $ 374,816
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation 34,461 30,438
Amortization 6,750 6,598
Share-based compensation 22,437 17,385
Equity in earnings of unconsolidated investments, net (51) (56)
Other 3,489 459
Changes in operating assets and liabilities, net of effects of acquisitions:    
Receivables (134,083) (123,914)
Product inventories 264,883 77,407
Prepaid expenses and other assets 19,765 73,226
Accounts payable (225,440) (69,794)
Accrued expenses and other liabilities 63,252 (100,822)
Net cash provided by operating activities 419,824 285,743
Investing activities    
Acquisition of businesses, net of cash acquired 0 (7,116)
Purchases of property and equipment, net of sale proceeds (49,772) (48,123)
Other investments, net 2,328 (508)
Net cash used in investing activities (47,444) (55,747)
Financing activities    
Proceeds from revolving line of credit 1,351,300 1,417,100
Payments on revolving line of credit (1,496,400) (1,390,400)
Proceeds from term loan under credit facility 0 125,000
Payments on term loan under credit facility 0 (87,500)
Proceeds from asset-backed financing 390,300 437,600
Payments on asset-backed financing (278,800) (370,400)
Payments on term facility 0 (19,938)
Proceeds from short-term borrowings and current portion of long-term debt 7,103 17,431
Payments on short-term borrowings and current portion of long-term debt (6,555) (16,523)
Payments of deferred financing costs (359) (1,397)
Payments of excise tax on repurchases of common stock (2,974) 0
Proceeds from stock issued under share-based compensation plans 5,018 9,203
Payments of cash dividends (140,105) (138,664)
Repurchases of common stock (198,046) (163,884)
Net cash used in financing activities (369,518) (182,372)
Effect of exchange rate changes on cash and cash equivalents (2,168) 2,997
Change in cash and cash equivalents 694 50,621
Cash and cash equivalents at beginning of period 104,963 77,862
Cash and cash equivalents at end of period $ 105,657 $ 128,483